Healthcare provider profile · identity verified

Matthew Tornga, D.O.

Family Practice · WEST OLIVE, MI · NPI 1902255714

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	709	200
Lisinopril	Lisinopril	296	93
Rosuvastatin Calcium	Rosuvastatin Calcium	283	101
Losartan Potassium	Losartan Potassium	280	81
Levothyroxine Sodium	Levothyroxine Sodium	254	63
Omeprazole	Omeprazole	252	72
Tamsulosin Hcl	Tamsulosin Hcl	234	67
Metoprolol Succinate	Metoprolol Succinate	215	66
Mounjaro	Tirzepatide	190	35
Eliquis	Apixaban	189	48
Amlodipine Besylate	Amlodipine Besylate	175	57
Metformin Hcl Er	Metformin Hcl	165	48
Gabapentin	Gabapentin	158	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	156	39
Hydrochlorothiazide	Hydrochlorothiazide	145	47
Trulicity	Dulaglutide	129	18
Albuterol Sulfate Hfa	Albuterol Sulfate	127	38
Duloxetine Hcl	Duloxetine Hcl	118	31
Furosemide	Furosemide	115	36
Sertraline Hcl	Sertraline Hcl	115	28
Carvedilol	Carvedilol	110	31
Finasteride	Finasteride	102	29
Metformin Hcl	Metformin Hcl	100	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	99	30
Simvastatin	Simvastatin	96	24
Allopurinol	Allopurinol	93	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	86	26
Trazodone Hcl	Trazodone Hcl	86	27
Pregabalin	Pregabalin	84	18
Montelukast Sodium	Montelukast Sodium	83	18
Pantoprazole Sodium	Pantoprazole Sodium	73	25
Escitalopram Oxalate	Escitalopram Oxalate	72	19
Metoprolol Tartrate	Metoprolol Tartrate	71	22
Donepezil Hcl	Donepezil Hcl	66	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	66	11
Xarelto	Rivaroxaban	63	15
Potassium Chloride	Potassium Chloride	62	22
Glipizide	Glipizide	61	19
Clopidogrel	Clopidogrel Bisulfate	59	15
Farxiga	Dapagliflozin Propanediol	57	16
Prednisone	Prednisone	57	34
Citalopram Hbr	Citalopram Hydrobromide	56	14
Clonazepam	Clonazepam	55	suppressed
Famotidine	Famotidine	55	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	11
Warfarin Sodium	Warfarin Sodium	54	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	53	13
Atenolol	Atenolol	52	15
Bupropion Xl	Bupropion Hcl	52	16
Pravastatin Sodium	Pravastatin Sodium	52	15
Tramadol Hcl	Tramadol Hcl	51	16
Buspirone Hcl	Buspirone Hcl	50	18
Pioglitazone Hcl	Pioglitazone Hcl	49	14
Ezetimibe	Ezetimibe	47	16
Fluticasone Propionate	Fluticasone Propionate	46	13
Hydroxyzine Hcl	Hydroxyzine Hcl	46	14
Methocarbamol	Methocarbamol	43	18
Ozempic	Semaglutide	43	suppressed
Cephalexin	Cephalexin	42	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	14
Lovastatin	Lovastatin	39	suppressed
Myrbetriq	Mirabegron	37	16
Nystatin	Nystatin	37	20
Spironolactone	Spironolactone	37	11
Lorazepam	Lorazepam	36	suppressed
Alendronate Sodium	Alendronate Sodium	34	15
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	34	suppressed
Meloxicam	Meloxicam	34	13
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Celecoxib	Celecoxib	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	11
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	23
Mirtazapine	Mirtazapine	30	suppressed
Ondansetron Odt	Ondansetron	30	11
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Aripiprazole	Aripiprazole	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Alprazolam	Alprazolam	26	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	16
Clobetasol Propionate	Clobetasol Propionate	25	14
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	23	suppressed
Ramipril	Ramipril	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Mupirocin	Mupirocin	19	15
Temazepam	Temazepam	19	suppressed
Azithromycin	Azithromycin	18	13
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Ciclopirox	Ciclopirox	13	11
Diazepam	Diazepam	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Fluorouracil	Fluorouracil	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error